###begin article-title 0
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
###end article-title 0
###begin p 1
Conceived and designed the experiments: JZ CSL MR. Performed the experiments: JZ AC BG CSL WAT. Analyzed the data: JZ AC CSL MER EJHJW MR. Contributed reagents/materials/analysis tools: BG CSL MER EJHJW MR. Wrote the paper: JZ MR.
###end p 1
###begin p 2
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 884 885 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1103 1104 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1756 1757 1748 1749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 1012 1015 <span type="species:ncbi:10376">EBV</span>
###xml 1035 1040 <span type="species:ncbi:9606">human</span>
###xml 1144 1147 <span type="species:ncbi:10376">EBV</span>
###xml 1559 1564 <span type="species:ncbi:9606">human</span>
###xml 1600 1603 <span type="species:ncbi:10376">EBV</span>
###xml 1729 1732 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) is a human herpesvirus that persists as a largely subclinical infection in the vast majority of adults worldwide. Recent evidence indicates that an important component of the persistence strategy involves active interference with the MHC class I antigen processing pathway during the lytic replication cycle. We have now identified a novel role for the lytic cycle gene, BILF1, which encodes a glycoprotein with the properties of a constitutive signaling G-protein-coupled receptor (GPCR). BILF1 reduced the levels of MHC class I at the cell surface and inhibited CD8+ T cell recognition of endogenous target antigens. The underlying mechanism involves physical association of BILF1 with MHC class I molecules, an increased turnover from the cell surface, and enhanced degradation via lysosomal proteases. The BILF1 protein of the closely related CeHV15 gamma1-herpesvirus of the Rhesus Old World primate (80% amino acid sequence identity) downregulated surface MHC class I similarly to EBV BILF1. Amongst the human herpesviruses, the GPCR encoded by the ORF74 of the KSHV gamma2-herpesvirus is most closely related to EBV BILF1 (15% amino acid sequence identity) but did not affect levels of surface MHC class I. An engineered mutant of BILF1 that was unable to activate G protein signaling pathways retained the ability to downregulate MHC class I, indicating that the immune-modulating and GPCR-signaling properties are two distinct functions of BILF1. These findings extend our understanding of the normal biology of an important human pathogen. The discovery of a third EBV lytic cycle gene that cooperates to interfere with MHC class I antigen processing underscores the importance of the need for EBV to be able to evade CD8+ T cell responses during the lytic replication cycle, at a time when such a large number of potential viral targets are expressed.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 246 252 <span type="species:ncbi:9606">people</span>
###xml 300 303 <span type="species:ncbi:10376">EBV</span>
###xml 446 449 <span type="species:ncbi:10376">EBV</span>
###xml 616 619 <span type="species:ncbi:10376">EBV</span>
###xml 845 848 <span type="species:ncbi:10376">EBV</span>
###xml 1290 1293 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) is a herpesvirus and an important human pathogen that can cause diseases ranging from non-malignant proliferative disease to fully malignant cancers of lymphocytes and epithelial cells. Nevertheless, the vast majority of people in all populations worldwide are infected with EBV. After primary infection the virus persists for the life of the infected individual, and usually without clinical symptoms. To understand how EBV causes disease, we also need to know how this virus is able to persist in healthy individuals with potent immune-responses. A picture is emerging which suggests that EBV, similar to non-tumorigenic herpesvirus, has multiple co-operating mechanisms to modulate immune responses by interfering with antigen processing pathway in cells undergoing lytic virus replication. We have now identified an EBV-encoded protein, BILF1, which targets MHC class I molecules for lysosomal degradation, leading to impaired recognition by immune T cells. BILF1 is a constitutively active G-protein-coupled receptor, but its effect on MHC class I degradation is independent of its signaling functions, and the molecular mechanisms are distinct from those identified in other viruses that induce degradation of MHC class I. This work aids our understanding of EBV biology and emphasizes the complexity of mechanisms evolved by viruses to enable persistent infection.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 577 580 574 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wilkinson1">[1]</xref>
###xml 651 652 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 805 808 802 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hengel1">[2]</xref>
###xml 809 812 806 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lehner1">[4]</xref>
###xml 818 821 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Ahn2">[5]</xref>
###xml 822 825 819 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Park1">[7]</xref>
###xml 835 838 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Furman1">[8]</xref>
###xml 1065 1068 1062 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wiertz1">[9]</xref>
###xml 1069 1073 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Jones2">[11]</xref>
###xml 465 486 <span type="species:ncbi:10359">human cytomegalovirus</span>
Viruses that persist asymptomatically in infected individuals need to evade or modulate immune responses, and particularly the adaptive T cell responses. A universal mechanism for virus persistence involves latency, where viral genes are transcriptionally silenced and, therefore, not available as targets for immune effectors. In addition, viruses may exhibit active immune-evasion mechanisms. In this context, the herpesviruses are paradigmatic. For example, the human cytomegalovirus (HCMV, a beta-herpesvirus), encodes at least 25 proteins with immune-modulating functions [1], of which 5 can impair antigen presentation via MHC-class I to the CD8+ T cell responses: US6 binds to the transporter associated with antigen processing (TAP) complex to inhibit peptide transport from the cytosol to the ER [2]-[4], US3 [5]-[7] and US10 [8] interfere with the maturation of MHC class I heavy chains and their egress from the ER, while US2 and US11 trigger retrograde transport of MHC class I from the ER to the cytosol with subsequent proteasome-mediated degradation [9]-[11].
###end p 6
###begin p 7
###xml 35 36 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 194 198 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 493 497 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 498 502 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-ThorleyLawson1">[13]</xref>
###xml 830 834 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-ThorleyLawson2">[14]</xref>
###xml 1114 1115 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1124 1128 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 1129 1133 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-ThorleyLawson2">[14]</xref>
###xml 1134 1138 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop1">[15]</xref>
###xml 1306 1310 1302 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 1311 1315 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-ThorleyLawson2">[14]</xref>
###xml 1316 1320 1312 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop1">[15]</xref>
###xml 1391 1395 1387 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Gregory1">[16]</xref>
###xml 1396 1400 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe1">[17]</xref>
###xml 1485 1486 1481 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1514 1521 1510 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1521 1525 1517 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 1526 1530 1522 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-ThorleyLawson2">[14]</xref>
###xml 1531 1535 1527 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop1">[15]</xref>
###xml 1664 1668 1660 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rickinson1">[12]</xref>
###xml 1669 1673 1665 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Purtilo1">[18]</xref>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 428 431 <span type="species:ncbi:10376">EBV</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 518 521 <span type="species:ncbi:10376">EBV</span>
###xml 722 725 <span type="species:ncbi:10376">EBV</span>
###xml 1469 1472 <span type="species:ncbi:10376">EBV</span>
###xml 1564 1567 <span type="species:ncbi:10376">EBV</span>
###xml 1655 1663 <span type="species:ncbi:9606">patients</span>
###xml 1772 1775 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) is a gamma1-herpesvirus whose normal biology is fundamentally distinct from most other human herpesviruses in that it has growth-transforming activity for human B cells [12]. This provides an alternative strategy for replicating virus genomes in proliferating cells without necessarily producing infectious viral progeny. This is a potentially dangerous strategy and it is unsurprising, therefore, that EBV is associated with the pathogenesis of certain human cancers [12],[13]. Nevertheless, EBV has evolved to persist asymptomatically in most immunocompetent individuals, and it is ubiquitous in adult populations worldwide. This successful persistence is largely attributable to the ability of EBV to establish various types of 'latency' (i.e. not producing infectious virus progeny) in lymphoid cells [14]. It is notable that the most restricted forms of latency (which involve expression either of no viral genes, or of non-coding small RNAs and possibly the poorly immunogenic EBNA1 and/or LMP2A proteins) are normally associated with quiescent cells and can evade recognition by CD8+ T cells [12],[14],[15]. In contrast, the form of latency associated with growth transformation is characterized by expression of at least 8 viral proteins, including immunodominant antigens [12],[14],[15], together with enhanced expression of antigen presentation components [16],[17] that render the cells susceptible to recognition and elimination by EBV-specific CD8+ cytotoxic T cell responses in vivo[12],[14],[15]. The increased incidence of EBV-associated B lymphoproliferative disease in iatrogenically immunosuppressed transplant patients [12],[18] emphasizes the need for adaptive T cell immune responses to prevent uncontrolled proliferation of EBV-transformed B cells.
###end p 7
###begin p 8
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop1">[15]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Keating1">[19]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Pudney1">[20]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Ressing1">[21]</xref>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe2">[22]</xref>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNLF2a</italic>
###xml 935 940 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BGLF5</italic>
###xml 998 1002 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop2">[23]</xref>
###xml 1020 1024 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe2">[22]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zuo1">[24]</xref>
###xml 25 28 <span type="species:ncbi:10376">EBV</span>
###xml 300 303 <span type="species:ncbi:10376">EBV</span>
###xml 338 341 <span type="species:ncbi:10376">EBV</span>
###xml 469 472 <span type="species:ncbi:10376">EBV</span>
While the interaction of EBV with the host immune responses differs from non-oncogenic herpesviruses during the growth-transforming phase of virus infection, it does share many properties with non-oncogenic herpesviruses during the lytic virus replication phase of the viral life-cycle. Responses to EBV lytic cycle antigens dominate the EBV-specific T cell response in both primary and persistent infection with the virus, but the ability of CD8+ T cells to recognize EBV-infected B cells in lytic cycle is compromised by a reduced expression of cell surface MHC class I [15],[19],[20]. The levels of cell surface MHC class I in lytic cycle reflect active interference with the antigen processing pathway by mechanisms that are poorly understood but which are at least in part due to an impairment of TAP-dependent peptide transport into the ER [21] and by host protein synthesis shutoff [22]. The early lytic cycle genes, BNLF2a and BGLF5 were recently identified as genes targeting TAP function [23] and host-shutoff [22],[24] respectively. While BGLF5 protein remains expressed throughout lytic cycle, BNLF2a protein expression decreases within 24 hr of induction and probably only acts during the early stages of lytic cycle (N. Croft, D. Horst et al, manuscript in preparation).
###end p 8
###begin p 9
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Paulsen1">[25]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rosenkilde1">[27]</xref>
###xml 299 302 <span type="species:ncbi:10376">EBV</span>
In the present study, we have identified a third lytic cycle gene that actively interferes with MHC class I antigen presentation to CD8+ T cells by increasing the turnover of MHC class I molecules at the cell surface and targeting them for lysosomal degradation. This new immune-evasion function of EBV mapped to BILF1, which was previously identified as a rhodopsin-like seven-transmembrane segment G-protein coupled receptor (GPCR) with constitutive signaling functions [25]-[27]. We have characterized the molecular mechanisms by which BILF1 increases MHC class I turnover, and found them to be independent of its G-protein activating function and distinct from the mechanisms employed by other herpesviruses that target MHC class I for degradation.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
BILF1 affects MHC class I expression and antigen presentation to CD8+ T cells
###end title 11
###begin p 12
###xml 524 531 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g001">Fig. 1A</xref>
###xml 750 753 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LF2</italic>
###xml 755 760 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMRF2</italic>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF2</italic>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 856 862 856 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNLF2a</italic>
###xml 898 901 898 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LF1</italic>
###xml 906 911 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BXLF2</italic>
###xml 1206 1211 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 1259 1266 1259 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g001">Fig. 1B</xref>
###xml 40 43 <span type="species:ncbi:10376">EBV</span>
###xml 125 128 <span type="species:ncbi:10376">EBV</span>
###xml 887 890 <span type="species:ncbi:10376">EBV</span>
We initiated a systematic screen of the EBV lytic genes to identify viral products that might affect MHC class I expression. EBV genes were cloned into the bicistronic vector pCDNA3-IRES-nls-GFP, which co-expresses the inserted gene with GFP, then transfected into 293 and MJS cells. At 48 h after transfection, the cells were stained with PE-conjugated W6/32 mAb and the levels of surface MHC class I molecules were measured by flow cytometry. Representative results of W6/32 staining in transfected 293 cells are shown in Fig. 1A. As a negative control, 'empty' pCDNA3-IRES-nls-GFP vector was transfected, and as a positive control, a known immune-evasion gene was transfected using the pCDNA3-BNLF2a-IRES-nls-GFP vector. The results show that the LF2, BMRF2, and BILF2 had no effect on MHC class I levels, whereas BILF1 caused a reduction comparable to BNLF2a. In addition, two other EBV genes, LF1 and BXLF2 were also screened in the same set of experiments and had no effect on MHC class I levels (data not shown). This assay was then extended to a second cell line (MJS) chosen for its expression of MHC class II as well as MHC class I molecules, which confirmed the downregulation of MHC class I by BILF1, with no effect on the levels of MHC class II (Fig. 1B).
###end p 12
###begin title 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
BILF1 identified as a lytic gene that downregulates surface MHC class I.
###end title 13
###begin p 14
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 57 60 <span type="species:ncbi:10376">EBV</span>
293 (A) or MJS (B) cells were transfected with different EBV genes in the bi-cistronic vector, pCDNA3-IRES-nlsGFP. At 48 hr post-transfection, surface MHC class I was stained with PE-conjugated W6/32 mAb and (in MJS only) MHC class II was stained with PE-conjugated anti-DR mAb, YE2/36-HLK. Two-colour flow cytometry was used to analyse staining in the untransfected GFP- population, shown as the solid line histogram, and in the transfected GFP+ population, shown as the dashed line histogram. The grey histogram denotes background staining obtained with an isotype control PE-conjugated antibody.
###end p 14
###begin p 15
###xml 736 743 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Fig. 2A</xref>
###xml 1228 1235 1228 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Fig. 2B</xref>
###xml 1378 1385 1378 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Fig. 2B</xref>
###xml 1521 1528 1521 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Fig. 2B</xref>
These screening experiments suggested a specific effect on surface MHC class I expression by BILF1. To examine this in more detail, we generated a retroviral expression vector for BILF1, and transduced both 293 and MJS cells to generate stable cell lines expressing BILF1. Since the BILF1 in these retroviral vectors contained an N-terminal HA-tag sequence, expression of BILF1 in the transduced cells was initially confirmed by staining of viable cells with anti-HA mAb and flow cytometry analysis (data not shown). Staining with PE-W6/32 mAb confirmed that expression of MHC class I expression at the cell surface was reduced in BILF1-expressing 293 and MJS cells relative to paired lines transduced with a control retrovirus vector (Fig. 2A). This effect was reproducibly stronger in the stable retroviral transduced cells than in the previous transient-transfection experiments. No downregulation of MHC class II in MJS, nor of transferrin receptor (TfR) in 293 or MJS, was observed by flow cytometry (data not shown). Western blots of whole cell lysates showed that the effect of BILF1 on the levels of cell surface MHC class I were reflected by a similar decrease in the amount of total cellular MHC class I heavy chains (Fig. 2B). Notably, the levels of TAP-1 and TAP-2 components of the peptide transporter complex and calregulin were unaffected by expression of BILF1 (Fig. 2B). Levels of TfR receptor were unaffected in 293 cells but reproducibly showed a small increase, along with MHC class II, in MJS cells (Fig. 2B).
###end p 15
###begin title 16
Characterization of cells stably transduced with a BILF1 retroviral vector.
###end title 16
###begin p 17
###xml 618 619 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
(A) 293 or MJS cells were stably transduced with control (pQCXIH) or BILF1 (pQCXIH-HABILF1) retrovirus. Surface MHC class I molecules were stained with PE-conjugated W6/32 antibodies and analyzed by flow cytometry. The solid line histograms depict the surface HLA class I staining of control cell lines, while the dashed line histogram depicts the surface HLA class I staining of cell lines expressing BILF1. The grey histogram illustrates background staining obtained with an isotype control PE-conjugated antibody. (B) Total cell lysates were generated from the retrovirus-transduced 293 and MJS cell lines, and 2x105 cell equivalents were separated by SDS-PAGE and analyzed by Western Blotting with mAbs specific for BILF1 (3F10, anti-HA tag), MHC class I (HC10), MHC class II (DA6.147), TAP-1 (148.3), TAP-2 (435.3), TfR (H68.4) or with polyclonal antibodies to calregulin as a loading control.
###end p 17
###begin p 18
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 709 716 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g003">Fig. 3A</xref>
###xml 848 853 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BZLF1</italic>
###xml 935 940 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 1507 1512 1499 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BZLF1</italic>
###xml 1573 1574 1565 1566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 417 420 <span type="species:ncbi:10376">EBV</span>
###xml 1486 1489 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1557 1560 <span type="species:ncbi:10376">EBV</span>
The aforementioned results raised the possibility that BILF1 might cause an impairment of the antigen processing pathway that would affect antigen recognition by CD8+ T cell responses. To test this hypothesis, HLA-B8 positive MJS cells were transiently transfected with p509 plasmid together with control pCDNA3-IRES-nlsGFP vector or different amounts of pCDNA3-BILF1-IRES-nlsGFP. The p509 vector expresses BZLF1, an EBV lytic cycle protein that is the target of the HLA-B8 restricted 'RAK' CD8+ T cell effector clone. Following co-culture of RAK T cells with the transfected MJS target cells, the release of IFN-gamma was assayed by ELISA as a measure of T cell recognition. The representative experiment in Fig. 3A shows that the RAK clone did not respond to vector control transfected MJS, but showed clear recognition of cells transfected with BZLF1. This recognition was inhibited in a dose-dependent manner by co-transfection of BILF1, exceeding 90% inhibition at the highest dose of pCDNA3-BILF1-IRES-nlsGFP transfected. Similar results were obtained in 3 separate experiments. Western-blots of the transfected target cells (.. 3B) showed that BILF1 protein expression increased with increasing amounts of pCDNA3-BILF1-IRES-nlsGFP plasmid, as expected. Interestingly, the amount of BZLF1 protein also showed a smaller but reproducible concomitant increase in expression, possibly as a result of constitutive BILF1 signaling (e.g. activation of NFkappaB; see below) enhancing the CMV promoter driving BZLF1 expression in p509. A similar inhibition of EBV-specific CD8+ T cell recognition by BILF1 was observed in additional experiments performed with 293 cells transfected with the BMLF1 target recognized by HLA-A2 restricted T cell clones (data not shown).
###end p 18
###begin title 19
###xml 48 51 <span type="species:ncbi:10376">EBV</span>
BILF1 inhibits T cell recognition of endogenous EBV antigen in MJS cells.
###end title 19
###begin p 20
###xml 279 280 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 622 623 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
(A) MJS cells were co-transfected with 0.02 microg p509 plasmid (BZLF1 expression vector) and different amounts (0-2 microg) of pCDNA3-HABILF1-IRES-nlsGFP bulked to a constant amount of DNA with control plasmid. At 24 hr post-transfection, the MJS cells were co-cultured with CD8+ effector 'RAK' T cells for a further 18 hrs and the supernatants were tested for the release of IFN-gamma as a measure of T cell recognition. All results are expressed as IFN-gamma release in pg/ml and error bars indicate standard deviation of triplicate cultures. (B) Total cell lysates were generated from the above transfections, and 2x105 cell equivalents were separated and analyzed by Western Blotting using antibodies specific for BZLF1, HA tag (BILF1), or calregulin as a loading control.
###end p 20
###begin p 21
###xml 856 857 856 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 980 981 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1015 1022 1015 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g004">Fig. 4A</xref>
###xml 1227 1233 1227 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Fig. 2</xref>
###xml 33 36 <span type="species:ncbi:10376">EBV</span>
###xml 435 438 <span type="species:ncbi:10376">EBV</span>
In healthy infected individuals, EBV latency is established in the B lymphocyte pool, which implies that at some stage lytic cycle must occur in B cells for the virus to be transmitted to epithelial cells or other hosts. We therefore examined the effect of BILF1 expression in B cells. To simplify the experiment, we chose to use LCLs that had been established by infection of normal resting B cells with a BZLF1 knock-out recombinant EBV; this provided us with a range of endogenous latent proteins as target antigens in a good antigen-presenting host cell which was unable to enter lytic cycle and, therefore, unable to express BILF1 from the viral genome. These LCL were transduced with a PLZRS-BILF1-IRES-GFP retrovirus, and 6 days later were stained for surface MHC class I and class II molecules with PE-conjugated antibodies. The GFP positive (BILF1+) population was shown by flow cytometry to express almost 40% less surface MHC class I compared to the GFP negative (BILF1-) population in the same culture (Fig. 4A). The expression of BILF1 did not affect the expression of surface MHC class II molecules. The reduction in the expression of surface MHC class I by BILF1 was smaller than that seen in 293 and MJS cells (Fig. 2), but was reproducibly observed in 3 experiments with two different LCLs.
###end p 21
###begin title 22
###xml 101 104 <span type="species:ncbi:10376">EBV</span>
BILF1 downregulates surface MHC class I expression and inhibits the T cell recognition of endogenous EBV antigen in LCLs.
###end title 22
###begin p 23
###xml 292 293 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 656 657 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 663 664 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 672 673 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 680 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 763 764 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 812 813 812 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 720 723 <span type="species:ncbi:10376">EBV</span>
(A) LCLs were transduced with PLZRS-HABILF1-IRES-GFP retrovirus. After 6 days, surface MHC class I was stained with PE-conjugated W6/32 mAb and MHC class II was stained with PE-conjugated anti-DR mAb, YE2/36-HLK. Two-colour flow cytometry was used to analyze staining in the untransduced, GFP-, population, shown as the solid line histogram, and in the transduced GFP+ (BILF1+) population, shown as the dashed line histogram. The grey histogram denotes background staining obtained with an isotype control PE-conjugated antibody. (B) LCL cultures transduced with control retrovirus or with the BILF1 retrovirus were sorted by flow cytometry to generate GFP+/BILF1- and GFP+/BILF1+ lines to use as targets in assays with EBV-specific T cells. The control and BILF1+ LCL targets were incubated with HLA-matched CD8+ effector T cells clones specific for EBNA1 (HPV), EBNA3A (YPL), or LMP2A (CLG) peptides, or a CD4+ effector T cell clone specific for a BHRF1 (PYY) peptide. After 18 hrs the supernatants were tested for the release of IFN-gamma as a measure of T cell recognition. All results are expressed as IFN-gamma release in pg/ml and error bars indicate standard deviation of triplicate cultures.
###end p 23
###begin p 24
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 525 532 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g004">Fig. 4B</xref>
###xml 546 547 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 844 845 844 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 935 942 935 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g004">Fig. 4B</xref>
###xml 107 110 <span type="species:ncbi:10376">EBV</span>
###xml 477 480 <span type="species:ncbi:10376">EBV</span>
To examine the functional significance of this BILF1-mediated reduction of surface MHC class I expression, EBV-specific T cell recognition experiments were performed on GFP+ cells isolated on a fluorescence activated cell sorter after transduction with either a control retrovirus (PLZRS-IRES-GFP) or the BILF1 retrovirus (PLZRS-BILF1-IRES-GFP). These cells were used as targets in T cell assays with different effector cell clones specific for constitutively-expressed latent EBV proteins. The representative experiments in Fig. 4B show that CD8+ effectors specific for one of three different latent proteins (EBNA1, HLA-B35 restricted; EBNA3A, HLA-B35 restricted; and LMP2A, HLA-A2 restricted) all recognized the BILF1-expressing LCLs less efficiently than the control LCLs. In contrast, recognition of BHRF1 antigen by HLA-DR4 restricted CD4+ effectors was not significantly different between the control and BILF1-expressing LCLs (Fig. 4B). Similar results were obtained in 3 separate experiments.
###end p 24
###begin title 25
BILF1 decreases the half-life of newly-synthesised MHC class I molecules
###end title 25
###begin p 26
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
To further examine the mechanism of the effect of BILF1 on MHC class I, we conducted a pulse-chase analysis of radio-labeled molecules to study the fate of newly synthesized MHC class I molecules. Control and BILF1+ 293 cells were pulse-labeled with 35S-methionine/cysteine and chased at 37degreesC in medium containing cold methionine and cysteine. At each time point, cells were lysed in NP40 detergent buffer and immunoprecipitated with mAb W6/32, which reacts with properly assembled MHC class I complexes.
###end p 26
###begin p 27
###xml 591 592 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g005">Fig. 5A</xref>
In the first set of pulse-chase experiments, the immunopreciptated MHC class I heavy chains were treated with endoglycosidase H (Endo-H), an enzyme which deglycosylates newly-synthesized heavy chains but not the mature form that has been exported from the ER. Most MHC class I heavy chains were Endo-H-sensitive at the beginning of the chase, as expected for newly synthesised heavy chain in the ER. Within 30-60 min, nearly all heavy chains became Endo-H-resistant. The rate of conversion of MHC class I heavy chain to the Endo-H resistant form was similar in control 293 cells and in BILF1+ 293 cells (Fig. 5A). These results indicate that the export of MHC class I from the ER and its passage through the Golgi is not impeded by BILF1, and that BILF1 most probably acts at a later stage.
###end p 27
###begin title 28
Effect of BILF1 on maturation and degradation of MHC class I molecules.
###end title 28
###begin p 29
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 803 804 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) Acquisition of endoglycosidase H (Endo H) -resistance of MHC class I heavy chain. 293 cells (2x106) stably transduced with control or BILF1 retrovirus were metabolically labeled for 15 min with 35S-methionine/cysteine and chased for the indicated time periods. After lysis in NP-40 detergent buffer, samples were immunoprecipitated with mAb W6/32 and treated with Endo H enzyme. Protein samples were separated by 10% acrylamide SDS/PAGE gel, dried and exposed to autoradiography. (B) Kinetics of MHC class I molecule degradation. 293 cells (2x106) stably transduced with control or BILF1 retrovirus were metabolically labeled for 15 min and chased for the indicated time periods. After lysis in NP-40 detergent buffer, samples were immunoprecipitated with mAb W6/32 (HLA class I heavy chain and beta2-microglobulin) or H68.4 (TfR). Protein samples were separated by 10% SDS/PAGE gel, dried and exposed to autoradiography.
###end p 29
###begin p 30
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g005">Fig. 5B</xref>
###xml 384 385 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 499 500 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 512 532 509 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g005">Fig. 5B, lower panel</xref>
In order to compare the half life of MHC class I molecules, cells were pulsed with radiolabel for 15 min, then chased for up to 8 h before lysis and immunoprecipitation. As shown in Fig. 5B (upper and middle panels), both MHC class I heavy chain and its associated beta2-microglobulin showed a half-life of around 8 h in the control 293 cells, which was reduced to around 5 h in BILF1+ 293 cells. In the same experiment, immunoprecipitations of the TfR showed no difference between control and BILF1+ 293 cells (Fig. 5B, lower panel).
###end p 30
###begin p 31
It is worth noting that over a series of experiments the incorporation of radiolabel into MHC class I molecules was not reduced in BILF1-expressing 293 cells relative to the control cells, indicating that BILF1 did not inhibit their translation.
###end p 31
###begin title 32
Physical association of BILF1 with MHC class I complexes
###end title 32
###begin p 33
###xml 644 651 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g006">Fig. 6A</xref>
###xml 700 701 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1191 1198 1191 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g006">Fig. 6A</xref>
###xml 1335 1336 1335 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In the pulse-chase and immunoprecipitation of MHC class I, an additional co-precipitating band at around 33 kD was reproducibly observed in W6/32 immunoprecipitates of BILF1-293 lysates but not in control lysates (data not shown). To test the hypothesis that this band might be the smaller, non-glycosylated, form of BILF1 co-precipitating with MHC class I, we carried out a second round of precipitations on eluates from the W6/32 precipitations. The eluates were first diluted in lysis buffer, then equal aliquots were re-precipitated either with a mAb to the HA-tag of BILF1 or with the HC10 mAb to MHC class I free heavy chain. As shown in Fig. 6A, re-precipitation of the W6/32 eluate from BILF1+ 293 cells with anti-HA revealed a band at around 33 kD and a smear at 48-55 kD (lane 2) that were not present in the re-precipitation with HC10 mAb (lane 4), and neither were they detectable in the anti-HA re-preciptate of the control 293 sample (lane 1). These experiments indicated that BILF1 associated with the MHC class I complex. It is also worth noting that re-precipitation with HC10 mAb pulled down a ladder of bands above the MHC class I heavy chain (indicated with asterisks in Fig. 6A), which probably represent ubiquitinated MHC molecules; the intensity of these bands was indistinguishable between control 293 and BILF1+ 293 cells.
###end p 33
###begin title 34
BILF1 is physically associated with the MHC class molecule complex.
###end title 34
###begin p 35
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 52 53 52 53 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 65 66 65 66 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sc>
###xml 648 649 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 683 684 683 684 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 695 696 695 696 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sc>
(A) 293 cells (107) stably transduced with control (c) or BILF1 (b) retrovirus were metabolically labeled for 15 min and chased for 20 min. After lysis in NP-40 buffer and immunoprecipitation with mAb W6/32, the samples were dissociated by boiling in reducing sample buffer, and were re-precipitated with either 3F10 ( HA tag on BILF1) or HC10 (MHC class I heavy chain). Protein samples were separated by 10% acrylamide SDS/PAGE gel, dried and exposed to autoradiography. The arrowhead and bracket indicate the presence of 33 kD and 45-55 kD BILF1 bands, whilst the asterisks indicate probable ubiquitinated MHC class I species. (B) 293 cells (2x106) stably transduced with control (c) or BILF1(b) retrovirus were treated with concanamycin A (50 nM) for 20 hr prior to lysing the cells with NP40 detergent buffer and immunoprecipitation with antibodies specific for MHC class I (W6/32), HA tagged BILF1 (12CA5), or TfR (H68.4). Cell lysates and immune complexes were separated by SDS/PAGE gel, and analyzed by western blotting using antibodies specific for MHC class I (HC10), HA tagged BILF1 (3F10), and TfR (H68.4). The first two samples on the gel are total cell lysates representing 5% of the input lysate for immunoprecipitations.
###end p 35
###begin p 36
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g006">Fig. 6B</xref>
To confirm the association of MHC class I with BILF1, additional immunoprecipitations were conducted with lysates from non-radiolabeled cells. Here, control 293 and BILF1+ 293 cells were again solubilized in NP40 detergent buffer, then immunoprecipitated with W6/32 (MHC class I), anti-HA (BILF1), or anti-TfR, before analysis by Western blotting. As shown in Fig. 6B, some MHC class I molecules were co-precipitated by anti-HA mAb (lane 6, top blot), and some BILF1 molecules were co-precipitated by W6/32 mAb (lane 4, middle blot). In the control TfR immunoprecipitations, no co-precipitation of MHC class I or BILF1 was observed (lane 8, top and middle blots). Taken together, the radiolabeled and cold immunoprecipitation data provide compelling evidence that BILF1 physically associates with the MHC class I molecules. Indeed, since weak co-precipitating BILF1 bands were even seen immediately following a 15 min pulse-label (data not shown), it is likely that the interaction first occurs in the ER.
###end p 36
###begin title 37
BILF1 is associated with MHC class I molecules on the cell surface and increases their rate of internalization
###end title 37
###begin p 38
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wiertz1">[9]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Jones2">[11]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Reusch1">[28]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Coscoy1">[29]</xref>
###xml 358 364 <span type="species:ncbi:10090">murine</span>
###xml 365 368 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
For other viral proteins known to target MHC class I molecules for degradation, three broad mechanisms have been identified: either they induce retrograde transport from the ER to the cytosol for degradation by proteasomes, as exemplified by HCMV US2 and US11 [9]-[11]; or they redirect them to endolysosomal vesicles for degradation, exemplified by gp48 of murine CMV [28]; or they trigger enhanced endocytosis of MHC class I from the cell surface, followed by lysosomal degradation, as exemplified by K3 and K5 of KSHV [29].
###end p 38
###begin p 39
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7A</xref>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7B</xref>
In order to investigate which of these mechanisms might be employed by BILF1, we first examined the cellular localisation of BILF1. Confocal microscopy of BILF1-espressing 293 cells showed that BILF1 was predominantly located in the plasma membrane (Fig. 7A). Since antibodies to the HA-tag engineered to the N-terminus of BILF1 allowed detection of BILF1 at the surface of viable cells, we were able to examine whether the association between MHC class I molecules and BILF1 can also be demonstrated at the cell surface. Thus, viable control 293 and BILF1+ 293 cells were first incubated with W6/32 (MHC class I), anti-HA (BILF1), or anti-TfR on ice to allow the antibodies to bind to the surface antigen. After removal of excess unbound antibodies by washing, the cells were then solubilized in NP40 detergent buffer and the antibody:antigen complexes precipitated with protein A/G beads. As shown in Fig. 7B, some MHC class I molecules were co-precipitated by anti-HA mAb (sample 4, upper blot), and some BILF1 molecules were co-precipitated by W6/32 mAb (sample 2, lower blot). In the control TfR immunoprecipitations, no co-precipitation of MHC class I or BILF1 was observed (sample 6).
###end p 39
###begin title 40
BILF1 associates with MHC class I molecules at the cell surface and increases their rate of internalization.
###end title 40
###begin p 41
###xml 607 608 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 642 643 640 641 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 655 656 653 654 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sc>
###xml 975 982 973 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g006">Fig. 6B</xref>
###xml 179 182 <span type="species:ncbi:10116">rat</span>
###xml 240 244 <span type="species:ncbi:9925">goat</span>
###xml 250 253 <span type="species:ncbi:10116">rat</span>
###xml 1491 1495 <span type="species:ncbi:9925">goat</span>
###xml 1501 1506 <span type="species:ncbi:10090">mouse</span>
(A) BILF1 is predominantly localized at the cell surface. 293 cells stably transduced with BILF1 retrovirus were grown on glass slides, fixed and permeabilized, then stained with rat anti-HA (3F10) primary antibodies and Alexa Fluor(R) 594 goat anti-rat IgG. The nuclei were counterstained with DAPI. The stained slides were analyzed with a laser scanning confocal microscope, and the three photographs show different 1 micron-thick sections through representative cells. BILF1 stained red, and the nuclei stained blue. (B) BILF1 and MHC class I molecules co-precipitate at the cell surface. 293 cells (2x106) stably transduced with control (c) or BILF1 (b) retrovirus were incubated with saturating concentrations of antibodies specific for MHC class I (W6/32), TfR (H68.4) or HA tagged BILF1 (3F10) on ice. After washing away excess antibody, the cells were lysed with NP40 detergent buffer, then precipitated with protein A/G beads and subjected to western-blotting as in Fig. 6B, using antibodies specific for MHC class I (HC10) and HA tagged BILF1 (3F10). (C) BILF1 increases the rate of internalization of MHC class I, but not class II, from the cell surface. MJS cells stably transduced with control or BILF1 retrovirus were incubated at 0degreesC with saturating concentrations of mAb to MHC class I (W6/32; top graph) or MHC class II (L234; bottom graph), then washed and incubated at 37degreesC for different periods of time. The cells were subsequently stained with PE-conjugated goat anti-mouse IgG antibody, and analyzed by flow cytometry. The mean fluorescence intensities of staining were averaged for triplicate samples, and normalized to the initial time 0 min samples. (D) BILF1 increases the rate of internalization, but not the rate of appearance, of MHC class I at the cell surface. Top graph: 293 cells stably transduced with control or BILF1 retrovirus were incubated at 0degreesC with saturating concentrations of mAb to MHC class I (W6/32), then treated exactly as for the internalization assay performed with MJS cells in panel C. Bottom graph: replicate aliquots of the saturated W6/32-bound cells were harvested at the indicated time points, and the appearance of new MHC class I molecules was assayed by staining with PE-conjugated W6/32 antibody. The mean fluorescence intensities of staining were averaged for triplicate samples.
###end p 41
###begin p 42
###xml 269 276 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7C</xref>
###xml 635 655 635 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7D, upper graph</xref>
###xml 871 872 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 976 996 976 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7D, lower graph</xref>
###xml 1221 1241 1221 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7D, upper graph</xref>
###xml 1269 1278 1269 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Fig. 7A&#8211;D</xref>
We next asked whether BILF1 enhances the endocytosis of surface MHC molecules. In MJS cells, BILF1 substantially increased the rate of disappearance of MHC class I molecules from the cell surface, but did not affect the rate of disappearance of MHC class II molecules (Fig. 7C). Similar results were obtained with LCLs that had been transduced with a BILF1 retrovirus (data not shown). In 293 cells, expression of BILF1 reproducibly increased the rate of disappearance of MHC class I molecules from the cell surface, although the magnitude of the effect was masked by the unusually high rate of disappearance in the control 293 cells (Fig. 7D, upper graph). Importantly, the rate of appearance of new MHC class molecules at the cell surface was identical for the first 30 min of analysis; thereafter, the appearance of new MHC class I molecules reached a plateau in BILF1+ cells, while new molecules continued to accumulate for at least a further 30 min in control 293 cells (Fig. 7D, lower graph). We interpret the differences between control and BILF1 cells in these latter experiments to be due to the effect of the increased rate of internalisation of MHC class I molecules that becomes apparent after 20-30 min (see Fig. 7D, upper graph). Together, the results in Fig. 7A-D suggest that BILF1 targets the mature MHC class I complexes for degradation after they reach the cell surface.
###end p 42
###begin title 43
Lysosomal inhibitors block BILF1-induced degradation of MHC class I
###end title 43
###begin p 44
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Drose1">[30]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Clague1">[31]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Grinde1">[32]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lee1">[33]</xref>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 516 523 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g008">Fig. 8A</xref>
###xml 833 840 833 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g008">Fig. 8A</xref>
We used a panel of inhibitors to identify the mechanism of BILF1-induced degradation of MHC class I molecules, including: bafilomycin A1 and concanamycin A, which can inhibit proteolysis by raising endolysosomal pH [30],[31]; leupeptin, which inhibits cysteine and serine proteases [32]; and the proteasome inhibitor, MG132 [33]. Control and BILF1+ 293 cells were incubated with or without these inhibitors for 20 hr before harvesting the cells for Western blot analysis. The representative blot probed with HC10 in Fig. 8A shows that bafilomycin A1, concanamycin A, and leupeptin all restored the level of MHC class I heavy chains in BILF1-293 cells to the same levels seen in control-293. The blots from three independent experiments were quantitated by densitometry, and the mean values shown in the histogram beneath the blot in Fig. 8A.
###end p 44
###begin title 45
Lysosomal inhibitors block BILF1-enhanced degradation of MHC class I.
###end title 45
###begin p 46
###xml 47 48 47 48 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 61 62 61 62 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sc>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1031 1032 1027 1028 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 1044 1045 1040 1041 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sc>
###xml 868 872 <span type="species:ncbi:9925">goat</span>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
(A) 293 cells stably transduced with control- (c) or BILF1- (b) retrovirus were treated with or without Bafilomycin A1, concanamycin A, or leupeptin for 20 hr. Lysates from 2x105 cell equivalents were separated by SDS/PAGE gel, and analyzed by western blotting using antibodies specific for MHC class I (HC10) and calregulin. The blot is one representative of three independent experiments. The histogram shows the mean results (+/-S.D.) of quantification by densitometry of all the blots from 3 independent experiments, where the densities of the HC10 bands were normalized relative to their own calregulin loading control. (B) 293 cells stably transduced with control or BILF1 retrovirus were treated with concanamycin A (50 nM) for 6 hr prior to fixation and permeabilization with methanol/acetone, then stained with W6/32 primary antibodies and Alexa Fluor(R) 488 goat anti-mouse IgG secondary antibodies. The photographs were obtained with a conventional fluorescence microscope. (C) 293 cells stably transduced with control (c) or BILF1 (b) retrovirus were treated with or without the proteasome inhibitor, MG132, for 20 hr, and analyzed by western blot as in panel A. The additional, lower molecular weight species detected is probably deglycosylated and/or partially degraded free heavy chain that is normally targeted for proteasomal degradation.
###end p 46
###begin p 47
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g008">Fig. 8B</xref>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 412 413 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 572 579 572 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g008">Fig. 8C</xref>
Fluorescence microscopy of BILF1+ cells treated with lysosomal inhibitors revealed a marked accumulation of intracellular MHC class I staining that was not observed in BILF1- cells treated with lysosomal inhibitor (Fig. 8B), nor in BILF1+ cells treated with the proteasome inhibitor, MG132 (data not shown). Furthermore, quantitation of the total cell MHC class I protein in Western blots revealed that the BILF1+ 293 cells retained their overall reduced expression of MHC class I molecules relative to control 293 cells following treatment with the proteasome inhibitor (Fig. 8C).
###end p 47
###begin p 48
###xml 31 38 31 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g007">Figs. 7</xref>
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g008">8</xref>
Taken together, the results in Figs. 7 and 8 suggest that the accelerated degradation induced by BILF1 occurs within an endolysosomal compartment following internalisation of MHC class I complexes from the cell surface.
###end p 48
###begin title 49
Comparison of BILF1/GPCR homologs
###end title 49
###begin p 50
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rosenkilde1">[27]</xref>
###xml 214 215 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 314 321 310 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g009">Fig. 9A</xref>
###xml 385 386 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 548 555 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g009">Fig. 9A</xref>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 406 409 <span type="species:ncbi:10376">EBV</span>
###xml 537 540 <span type="species:ncbi:10376">EBV</span>
It is well established that many, if not all, herpesviruses encode proteins with features of GPCRs [27]. The most closely related vGPCR to BILF1 amongst the human herpesviruses is the ORF74 product of KSHV (a gamma2-herpesvirus), which shares just 15% amino acid sequence identity and 29.7% similarity with BILF1 (Fig. 9A). However, a more closely related herpesvirus , CeHV15 (a gamma1-herpesvirus, as is EBV), of the Rhesus Old World primate encodes a BILF1 homolog sharing 80.4% amino acid sequence identity and 88.5% similarity with EBV BILF1 (Fig. 9A).
###end p 50
###begin title 51
The ability of BILF1 homologs to downregulate MHC class I.
###end title 51
###begin p 52
###xml 451 457 451 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g001">Fig. 1</xref>
###xml 35 38 <span type="species:ncbi:10376">EBV</span>
###xml 50 74 <span type="species:ncbi:45455">rhesus lymphocryptovirus</span>
###xml 262 265 <span type="species:ncbi:10376">EBV</span>
(A) Multiple sequence alignment of EBV-BILF1, the rhesus lymphocryptovirus CeHV15-BILF1, and KSHV-ORF74. The alignment was done with ClustalW version 1.8, and shading was done with Boxshade version 3.21, available at . (B) 293 or MJS cells were transfected with EBV-BILF1, CeHV15-BILF1 or KSHV-ORF74 genes in the bicistronic vector, pCDNA3-IRES-nlsGFP. At 48 hr post-transfection, surface MHC class I molecules were stained and analyzed exactly as in Fig. 1.
###end p 52
###begin p 53
###xml 307 313 307 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g001">Fig. 1</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g009">Fig. 9B</xref>
###xml 57 60 <span type="species:ncbi:10376">EBV</span>
In order to investigate whether these vGPCRs shared with EBV BILF1 the ability to downregulate MHC class I, we cloned them into the bicistronic vector pCDNA3-IRES-nls-GFP and transiently transfected them into 293 and MJS cells, and analysed their effect on cell surface MHC class I expression exactly as in Fig. 1. The results illustrated by a representative experiment in Fig. 9B, show that Rhesus CeHV15-BILF1 clearly did reduce MHC class I expression at the cell surface, but that KSHV-ORF74 did not.
###end p 53
###begin title 54
Downregulation of MHC class I by BILF1 is independent of its signaling function
###end title 54
###begin p 55
###xml 93 99 93 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g009">Fig. 9</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rosenkilde1">[27]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wess1">[34]</xref>
###xml 847 855 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g010">Fig. 10A</xref>
###xml 1293 1301 1281 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g010">Fig. 10B</xref>
###xml 175 178 <span type="species:ncbi:10376">EBV</span>
###xml 318 321 <span type="species:ncbi:10376">EBV</span>
Since different vGPCRs activate different G-proteins and signalling pathways, the results in Fig. 9 could be interpreted as indicating that shared signalling functions of the EBV and CeHV15 vGPCRs determine their ability to downregulate MHC class I. To test this hypothesis, we obtained a signaling-negative mutant of EBV BILF1. The BILF1 polypeptide contains an EKT sequence in its predicted third transmembrane domain, which represents a conservative amino acid substitution of the 'DRY box' (i.e. residues with acidic, basic, polar side chains), known to be important in G-protein signaling [27],[34]. Substitution of an alanine for lysine at residue 122 abolished G-protein activation and BILF1 signaling function, as we observed by transfecting wild-type BILF1 or the K122A-BILF1 mutant into the HEK293-NFkappaB reporter line. The results in Fig. 10A are the mean of three independent experiments, and show that whereas transfection of wt-BILF1 typically induced more than a 5-fold increase in NFkappaB activity relative to the empty vector control transfectant, the K122A-BILF1 mutant did not induce any discernable NFkappaB activation above the vector control. In both 293 and MJS cells, transient transfection of the mutant K122A-BILF1 was able to cause downregulation of MHC class I (Fig. 10B). These results suggest that the ability of BILF1 to target MHC class I molecules for endolysosomal degradation is not critically dependent upon its signaling function.
###end p 55
###begin title 56
BILF1 signaling function is not required to downregulate MHC class I.
###end title 56
###begin p 57
###xml 526 532 516 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g001">Fig. 1</xref>
(A) Wild-type or K122A-mutant BILF1 expression plasmids were transfected into the HEK293-NFkappaB reporter cell line, and the degree of NFkappaB activation measured by detection of luciferase activity. The results are the mean+/-S.D. for three independent experiments performed in triplicate. (B) 293 and MJS cells were transfected with wild type BILF1 or mutant K122A-BILF1 genes in the bicistronic vector, pCDNA3-IRES-nlsGFP. At 48 hr post-transfection, surface MHC class I molecules were stained and analyzed exactly as in Fig. 1.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Paulsen1">[25]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Beisser1">[26]</xref>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 994 995 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1506 1510 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop2">[23]</xref>
###xml 1511 1515 1507 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Fogg1">[35]</xref>
###xml 1516 1520 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wang1">[36]</xref>
###xml 182 185 <span type="species:ncbi:10376">EBV</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 933 936 <span type="species:ncbi:10376">EBV</span>
###xml 1060 1063 <span type="species:ncbi:10376">EBV</span>
###xml 1113 1116 <span type="species:ncbi:10376">EBV</span>
###xml 1215 1218 <span type="species:ncbi:10376">EBV</span>
In this study we have shown that the BILF1 protein, which was recently identified as a constitutive signaling vGPCR [25],[26], can downregulate cell surface MHC class I and abrogate EBV-specific T cell recognition. The essential elements of the mechanism of this immune evasion function have been elucidated. Pulse-labeling and immunoprecipitation experiments with BILF1-transduced cells revealed that BILF1 associates with MHC class I molecules within 15 mins of biosynthesis. The MHC class I molecules can mature to the Endo H-resistant glycosylated form as normal, but were more rapidly internalized from the cell surface and were degraded by lysosomal enzymes. The effects of BILF1 on MHC class I were not critically dependent upon the activation of G-protein signaling, and were not exhibited by the most closely related human herpesvirus GPCR homolog, the ORF74 protein of KSHV, which has 15% amino acid sequence identity with EBV BILF1. Interestingly, the BILF1 homolog of a Rhesus gamma1-herpesvirus (CeHV15 BILF1, showing 80% amino acid identity with EBV BILF1) did downregulate MHC class I similarly to EBV BILF1. This observation reinforces the degree of similarity in the sequences and functions of the EBV and CeHV15, and strengthens the case for CeHV15 infection of Rhesus Macaques being an excellent animal model for understanding the interplay between immune responses and virus-infected cells during persistence of the virus in the healthy host and the development of virus-induced tumors [23],[35],[36].
###end p 59
###begin p 60
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe2">[22]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zuo1">[24]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop2">[23]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zuo1">[24]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Yuan1">[37]</xref>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Paulsen1">[25]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Beisser1">[26]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Yuan1">[37]</xref>
###xml 1165 1166 1165 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Pudney1">[20]</xref>
###xml 1373 1378 1373 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRF1</italic>
###xml 1421 1422 1421 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1548 1552 1548 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zeidler1">[38]</xref>
###xml 1569 1574 1569 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRF1</italic>
###xml 1714 1718 1714 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe2">[22]</xref>
###xml 1719 1723 1719 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zuo1">[24]</xref>
###xml 1912 1919 1912 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 118 136 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 163 166 <span type="species:ncbi:10376">EBV</span>
###xml 1534 1539 <span type="species:ncbi:9606">human</span>
Our in vitro studies, identifying a new function for BILF1, add to the complexity of the immune-evasion mechanisms of Epstein-Barr virus during lytic replication. EBV has now been demonstrated to target the MHC class I antigen processing pathway at the level of translation, through BGLF5 [22],[24]; peptide transport, through BNLF2a [23]; and by targeting mature MHC class I molecules for degradation, through BILF1. BGLF5 and BNLF2a are both products of early lytic cycle genes [24],[37], but there are conflicting reports on the early/late status of BILF1[25],[26],[37]. Our own results (D. van Leeuwen, unpublished) show that induction of BILF1 mRNA expression during lytic cycle is insensitive to phosphonoacetic acid treatment, indicating that it is an early gene, although its appearance is delayed relative to BNLF2a transcripts. The temporal expression of BNLF2a, BGLF5 and BILF1 proteins and their impact at different points along the antigen processing pathway, suggest that their cooperative effects will cause efficient abrogation of antigen presentation, particularly at the later stage of lytic cycle. This is consistent with the observation that CD8+ T cell responses to late lytic cycle antigens are rare compared to the responses to immediate-early and early antigens [20]. It has also been suggested that the viral IL-10 homolog (vIL-10) produced by the BCRF1 gene might be involved in evasion from CD8+ T cell responses since vIL-10 can selectively reduce levels of TAP-1 mRNA, and therefore peptide transport, in human B cells [38]. However, since BCRF1 is a late gene, any autocrine effects of vIL-10 on TAP-1 mRNA would be masked by the earlier expression of the host-shutoff protein, BGLF5 [22],[24]. In the context of immune-evasion, it is likely that secreted vIL-10 may be more relevant to bystander B cells being infected by the virus released from cells undergoing lytic replication in vivo, coupled with the effects of vIL-10 on T cell and NK cell functions.
###end p 60
###begin p 61
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Paulsen1">[25]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rosenkilde1">[27]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rosenkilde1">[27]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Guo1">[39]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Yang1">[41]</xref>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">US28</italic>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Stern1">[42]</xref>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hirsch1">[43]</xref>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Milne1">[44]</xref>
###xml 1681 1685 1670 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rowe2">[22]</xref>
###xml 1241 1245 <span type="species:ncbi:10368">HHV6</span>
###xml 1307 1311 <span type="species:ncbi:10368">HHV6</span>
BILF1 is a seven transmembrane segment GPCR which, like many vGPCRs encoded by herpesviruses, shares structural and functional characteristics with chemokine receptors [25]-[27]. One role of viral chemoreceptors is to contribute to efficient lytic replication cycle by reprogramming the host cell through multiple signaling pathways [27], a process that might aberrantly lead to cellular transformation and oncogenesis, as has been suggested for KSHV ORF74 [39]-[41]. In addition, it has long been recognized that viral chemoreceptors have the potential to contribute to immune-evasion strategies. For example, Bodaghi and colleagues reported in 1998 that one of the four vGPCRs of HCMV, encoded by US28, can modify the chemokine environment of infected cells by binding and internalizing MCP-1 (monocyte chemoattractant protein) and RANTES (regulated on activation, normal T cell expressed and secreted) to efficiently sequester these chemokines. In certain cellular contexts, i.e. latent infection of monocytes with HCMV, US28 can also transcriptionally upregulate MCP-1 expression [42], whilst during lytic cycle in fibroblasts the transcription of MCP-1 is downregulated [43], though not by US28. Similarly to HCMV US28, the U51 GPCR of HHV6 is also able to bind and sequester RANTES and MCP-1, but the HHV6 U51 additionally induces transcriptional downregulation of RANTES [44]. These examples of transcriptional regulation of immune-modulating chemokines by vGPCRs of beta-herpesvirus are likely to be more significant in the lytic cycle of this virus subfamily, where host protein synthesis shutoff is not a feature of lytic cycle as it is in alpha- and gamma-herpesviruses [22].
###end p 61
###begin p 62
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wang2">[45]</xref>
###xml 969 970 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 978 984 972 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g006">Fig. 6</xref>
###xml 1221 1222 1211 1212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1539 1543 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Paulsen1">[25]</xref>
Our observation with BILF1 represents the first example of a viral GPCR/chemokine receptor interfering directly with the MHC class I antigen processing pathway. Interestingly, a similar phenomenon was recently reported for the cellular chemokine receptor, CXCR4 [45]. Thus, CXCL12 ligand-induced activation of CXCR4 on malignant cancer cell lines and peripheral blood mononuclear cells triggered down-regulation of MHC class I from the cell surface. Mechanistically, this process involves physical association of CXCR4 with the beta2-microglobulin component of mature MHC class I complexes, ubiquitination of the MHC class I heavy chain, and endocytosis of MHC complexes into a late endosomal/lysosomal compartment where degradation presumably occurs. Although BILF1 is unable to directly associate with beta2-microglobulin (JZ, unpublished data) and we have no evidence that BILF1 induces ubiquination of MHC class I heavy chains above the levels seen in control BILF1- cells (Fig. 6), CXCR4 does share some broad features with the mechanism by which BILF1 downregulates MHC class I, which raises the possibility that targeting of the antigen processing pathway might not be a property uniquely associated with the gamma2-herpesvirus BILF1 vGPCRs. It is perhaps relevant that when co-expressed in the same cell, BILF1 and CXCR4 show almost complete co-localization (both being present predominantly in the plasma-membrane), whereas the KSHV-ORF74 and HCMV-US28 vGPCRs (predominantly intracellular) exhibit separate localizations to BILF1 [25].
###end p 62
###begin p 63
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Ahn2">[5]</xref>
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Furman1">[8]</xref>
###xml 423 426 423 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Wiertz1">[9]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Jones2">[11]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Coscoy1">[29]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Stevenson1">[46]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Ishido1">[47]</xref>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Coscoy2">[48]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hewitt1">[49]</xref>
###xml 1395 1399 1395 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hewitt1">[49]</xref>
###xml 1400 1404 1400 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Joazeiro1">[51]</xref>
Many other viral gene-products have been shown to target MHC class I molecules for degradation. Some, such as the US3, US10, US2 and US11 proteins of HCMV, target MHC molecules before they reach the cell surface, either by interfering with the maturation of MHC class I molecules and their egress from the ER [5]-[8] or by inducing retrograde transport from the ER to the cytosol with subsequent degradation by proteasomes [9]-[11]. Other viral proteins, such as the KSHV K3 and K5 proteins [29],[46],[47], induce endocytosis and lysosomal degradation of cell surface MHC class I complexes. Although BILF1 shares no obvious structural or sequence properties with any of these viral proteins, the mechanism of interference with MHC class I by BILF1 shares many features with those proteins that induce endocytosis of cell surface MHC class I molecules and subsequent degradation. However, whereas, KSHV K3 and K5 proteins were shown to induce ubiquitination of MHC class I heavy chains, which appears to be a signal for endocytosis and subsequent degradation [48],[49], we found no evidence that BILF1 induced ubiquitination of MHC class I heavy chains above the level seen in control BILF1-negative cells. Furthermore, BILF1 lacks a plant homeodomain (PHD) or RING-finger motif present in K3 and K5 proteins that are necessary for their ability to induce ubiquitination of MHC class I molecules [49]-[51].
###end p 63
###begin p 64
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Reusch1">[28]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Glosson1">[52]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Chaudhuri1">[53]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Janvier1">[54]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Greenberg1">[55]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Schwartz1">[56]</xref>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Kasper1">[57]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lubben1">[59]</xref>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Reusch1">[28]</xref>
###xml 29 35 <span type="species:ncbi:10090">murine</span>
###xml 36 39 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1032 1038 <span type="species:ncbi:10090">murine</span>
###xml 1039 1042 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Some viral proteins, such as murine CMV gp48 [28] and the HHV-6A/B U21 proteins [52], contain dileucine motifs in their cytosolic C-terminus that have been shown to be important for lysosomal targeting of MHC class I complexes, but no dileucine motif is present in the cytosolic domains of BILF1. The HIV-1 Nef protein contains a typical di-leucine motif that is involved in the binding of adapter proteins involved in membrane trafficking [53],[54], although mutation of this motif does not affect the ability of Nef to downregulate MHC class I [55]. Indeed, although Nef was one of the first viral proteins reported to induce endocytosis and degradation of MHC class I molecules from the cell surface [56], it is now unclear to what extent endocytosis of MHC class I accounts for its downregulation by Nef. An alternative explanation is that Nef acts predominantly by diverting intracellular MHC class I complexes to endosomes and lysosomes before they can reach the plasma-membrane [57]-[59]. This would make Nef more similar to murine CMV gp48 which also diverts MHC class I from the ER to the lysosomal compartment for degradation [28].
###end p 64
###begin p 65
Since BILF1 is predominantly located in the plasma membrane, our data on BILF1 suggest that endocytosis of surface MHC class I molecules associated with BILF1 is likely to be the main mechanism of targeting the MHC class I molecules to the lysosome. However, we cannot yet rule out the possibility that some MHC class I molecules might also be diverted before they reach the surface. An investigation of what adaptor molecules can associate with BILF1 will provide crucial information to elucidate the finer details of BILF1's mechanism of action. It also remains to be determined what are the sequence elements of BILF1 that are involved in its association with MHC class I molecules. Experiments are ongoing to resolve these unanswered questions.
###end p 65
###begin p 66
###xml 165 172 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g002">Figs. 2</xref>
###xml 173 173 173 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g003"/>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000255-g004">4</xref>
It is perhaps surprising that BILF1 can inhibit T cell recognition so efficiently when it has a comparatively small effect on the levels of surface MHC class I (see Figs. 2-4). There are a number of possible explanations for this. First, BILF1 might target different HLA alleles with different efficiency. Thus, while HLA-A2, -B8, and B35 might be efficiently removed from the cell surface for degradation, other alleles recognized by W6/32 antibody may be unaffected and will mask the full extent that selected MHC molecules are being degraded. Secondly, the association of BILF1 with MHC class I molecules in the ER might interfere with Tapasin or TAP binding and thus interfere with correct peptide loading, while stabilizing a defective MHC complex and allowing egress from the ER. Thirdly, the association of BILF1 with MHC class I molecules at the cell surface might directly interfere with recognition by TCR. None of these possibilities is mutually exclusive, and further work is ongoing to test them.
###end p 66
###begin p 67
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 241 244 <span type="species:ncbi:10376">EBV</span>
###xml 370 373 <span type="species:ncbi:10376">EBV</span>
In summary, through identifying and partially characterizing the molecular mechanisms of an immune-evasion function for BILF1, we have extended our understanding of the normal biology of an important human pathogen. The discovery of a third EBV lytic cycle gene that cooperates to interfere with MHC class I antigen processing underscores the importance of the need for EBV to be able to evade CD8+ T cell responses during the lytic replication cycle, at a time when such a large number of potential viral targets are expressed.
###end p 67
###begin title 68
Materials and Methods
###end title 68
###begin title 69
Plasmids and retroviral expression vectors
###end title 69
###begin p 70
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMRF2</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF2</italic>
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and BXLF2</italic>
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LF1</italic>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LF2</italic>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Delecluse1">[60]</xref>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ORF74</italic>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zhou1">[61]</xref>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BILF1</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rivailler1">[62]</xref>
###xml 655 661 655 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNLF2a</italic>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Hislop2">[23]</xref>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BZLF1</italic>
###xml 833 844 833 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BSLF2/BMLF1</italic>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Zuo1">[24]</xref>
###xml 4 7 <span type="species:ncbi:10376">EBV</span>
###xml 128 131 <span type="species:ncbi:10376">EBV</span>
###xml 295 319 <span type="species:ncbi:45455">Rhesus lymphocryptovirus</span>
###xml 651 654 <span type="species:ncbi:10376">EBV</span>
###xml 784 787 <span type="species:ncbi:10376">EBV</span>
###xml 829 832 <span type="species:ncbi:10376">EBV</span>
The EBV lytic genes BMRF2, BILF1, BILF2, and BXLF2 were PCR-amplified from the B95.8 virus sequences, and LF1 and LF2 from Raji EBV sequences, within the Bacterial artificial Chromosome (BAC) plasmid, 2089 [60]. The KSHV gene ORF74 was PCR-amplified from a KSHV BAC [61]. The BILF1 homolog of a Rhesus lymphocryptovirus was PCR-amplified from a cosmid derived from the CeHV15 virus, [62] that was kindly provided by F. Wang (Harvard Medical School, Boston). All the viral genes were subcloned into the EcoRI/NotI sites of pCDNA3-IRES-nls-GFP vector with an additional 5'-HA tag. All plasmids were verified by restriction digest and sequence analysis. EBV BNLF2a with 3'-HA tag in pCDNA3-IRES-nls-GFP vector has been described previously [23]. Expression plasmids p509, containing the EBV BZLF1 gene, and pCEP4-SM, containing the EBV BSLF2/BMLF1 spliced gene, have been described previously [24].
###end p 70
###begin p 71
Two retroviral vector systems were used. The Retro-Xtrade mark Universal Packaging System (Clontech Laboratories, Inc.) was used to prepare retrovirus based on the PQCXIH vector for hygromycin drug selection. The alternative vector, pLZRS-IRES-GFP, instead allowed coexpression of the marker gene GFP. The BILF1 gene with a 5'-HA tag was subcloned into each vector.
###end p 71
###begin title 72
Cells and transfections
###end title 72
###begin p 73
###xml 381 385 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Bauer1">[63]</xref>
###xml 518 522 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Johnson1">[64]</xref>
###xml 907 908 895 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1045 1049 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Rabin1">[65]</xref>
###xml 1102 1106 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Pudney1">[20]</xref>
###xml 179 185 <span type="species:ncbi:9913">bovine</span>
###xml 586 592 <span type="species:ncbi:9913">bovine</span>
###xml 891 894 <span type="species:ncbi:10376">EBV</span>
The HEK293 epithelial cell line (American Type Culture Collection) and derived cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and penicillin-streptomycin antibiotics. The HEK293-NFkappaB-luc cell line (kindly provided by G. Lipford, Munich) contained a stably transfected NFkappaB-luciferase promoter-reporter gene [63], and was maintained in medium supplemented with 0.7 mg/ml G418 as a selective agent. The MJS (Mel JuSol) melanoma-derived cell line [64] was maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and penicillin-streptomycin antibiotics. 293 and MJS cell lines transduced by PQCXIH-based retroviruses were maintained in their medium with 400 microg/ml hygromycin. For some experiments, 293 and MJS cells were transiently transfected with plasmid DNA using Lipofectamine 2000 (Invitrogen). EBV specific CD8+ cytotoxic T cells were grown in 10% FCS in RPMI-1640 medium supplemented with 30% supernatant from the IL-2-producing MLA 144 cell line [65] and 50 U/ml recombinant IL-2 as described elsewhere [20].
###end p 73
###begin title 74
Retroviral infection
###end title 74
###begin p 75
For the transduction of 293 cells and MJS cells, the packaging cell line (GP2-293) was transfected with retroviral vectors (PQCXIH or PQCXIH-BILF1) and PVSV-G to produce replication-defective viral particles. The supernatants containing recombinant retrovirus were harvested 48 hours after transfection, and filtered through a 0.22-microm pore, low protein-binding filter. To generate stable cell lines by transduction with PQCXIH-BILF1 or control PQCXIH-BILF1 retrovirus, 293 cells or MJS cells were infected with 1 ml retrovirus supernatants with polybrene added to 4 microg/ml final dilution. The stable cell lines were selected by 400 microg/ml hygromycin.
###end p 75
###begin p 76
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
For retrovirus transduction of LCLs, the packaging cell line (GP2-293) was transfected with retroviral vectors (PLZRS-IRES-GFP or PLZRS-BILF1-IRES-GFP) and PVSV-G to produce replication-defective viral particles. To generate stable cell lines by transduction with these viral vectors, the LCLs were infected with retrovirus supernatants and the GFP+ cells were sorted on a Cytomation MoFlo cell sorter at 72 hr post-infection.
###end p 76
###begin title 77
Antibodies
###end title 77
###begin p 78
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Young1">[66]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Barnstable1">[67]</xref>
###xml 274 278 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Stam1">[68]</xref>
###xml 420 424 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lampson1">[69]</xref>
###xml 831 835 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Meyer1">[70]</xref>
###xml 9 15 <span type="species:ncbi:10090">murine</span>
###xml 37 40 <span type="species:ncbi:10376">EBV</span>
###xml 110 116 <span type="species:ncbi:10090">Murine</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 335 341 <span type="species:ncbi:10090">murine</span>
###xml 790 796 <span type="species:ncbi:10090">murine</span>
###xml 994 1000 <span type="species:ncbi:10090">murine</span>
###xml 1016 1021 <span type="species:ncbi:9606">human</span>
###xml 1099 1103 <span type="species:ncbi:9925">Goat</span>
###xml 1184 1187 <span type="species:ncbi:10116">Rat</span>
###xml 1203 1208 <span type="species:ncbi:10090">mouse</span>
The BZ.1 murine mAb specific for the EBV BZLF1 encoded protein was generated in the authors' laboratory [66]. Murine mAbs used to detect human MHC class I were: W6/32 [67] which recognizes native beta2m-associated MHC class I (HLA-A, -B, and -C alleles) complexes; and HC10 [68], recognizing free HLA class I heavy chains. The DA6.147 murine mAb specific for HLA-DR alpha-chains was obtained from the ATCC, and mAb L234 [69] specific for HLA-DR beta-chains, was kindly provided by P. Cresswell (Howard Hughes Medical Institute, New Haven). For flow cytometry experiments, antibodies for detecting MHC class I and class II were purchased from Serotec, including phycoerythrin(PE)-conjugated anti-HLA A,B,C (MCA81PE; clone W6/32) andPE-conjugated anti-HLA DR (MCA71PE; clone YE2/36-HLK). The murine mAbs specific for the TAP1, 148.3 [70], and TAP2, 435.3, were kindly provided by R. Tampe (Wolfgang Goethe-University, Frankfurt) and by P.M. van Endert (Institute Necker, Paris) respectively. The murine mAb, H68.4, to human transferrin receptor (TfR) protein was purchased from Roche Diagnostics, and Goat antibodies to calregulin (sc6467) were purchased from Santa Cruz Biotechnology. Rat mAb, 3F10, and mouse mAb, 12CA5, directed against the influenza virus derived HA tag, were purchased from Roche Diagnostics and Santa Cruz Biotechnology respectively.
###end p 78
###begin title 79
Flow cytometry analysis of cell surface MHC molecules
###end title 79
###begin p 80
Cell surface expression of MHC class I on viable cells was determined by staining with PE-labeled W6/32 antibodies or PE-labeled isotype control mAb (both from Serotec) and detection on a Beckman Coulter XL flow cytometer. The data were analysed using Flowjo software (Tree Star).
###end p 80
###begin p 81
###xml 360 367 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 558 562 <span type="species:ncbi:9925">goat</span>
###xml 568 573 <span type="species:ncbi:10090">mouse</span>
To assay the kinetics of internalization of surface MHC class I and class II molecules, 293 cells or MJS cells were incubated for 60 min on ice with saturating amounts of W6/32 or L234 mAb, then washed three times in phosphate-buffered normal saline (PBS) and replaced in warm culture medium and incubated at 37degreesC for the length of time indicated in the results section. To terminate MHC/antibody complex internalization, cells were rapidly cooled to 0degreesC. Finally, the mAb-bound surface MHC molecules were stained at 0degreesC with PE-conjugated goat anti-mouse IgG2a antibody (Serotec), and cells were analyzed by flow cytometry.
###end p 81
###begin p 82
###xml 269 276 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
To assay the kinetics of appearance of surface MHC class I, 293 cells were incubated for 60 min on ice with saturating amounts of W6/32, then washed three times in PBS, replaced in warm culture medium and incubated at 37degreesC for the length of time indicated in the results section. To terminate further appearance of new surface MHC-I, cells were rapidly cooled to 0degreesC. Finally, the newly appeared surface MHC-I molecules were stained with PE-conjugated W6/32, and the cells were analyzed by flow cytometry.
###end p 82
###begin title 83
Western Blots
###end title 83
###begin p 84
###xml 291 292 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 805 810 <span type="species:ncbi:10090">mouse</span>
###xml 961 966 <span type="species:ncbi:10090">mouse</span>
###xml 1029 1032 <span type="species:ncbi:10116">rat</span>
###xml 1075 1079 <span type="species:ncbi:9925">goat</span>
Total cell lysates were denatured in reducing sample buffer (final concentration: 2% SDS, 72.5 mM Tris-HCl pH 6.8, 10% glycerol, 0.2 M sodium 2-mercaptoethane-sulfonate, 0.002% bromophenol blue), then sonicated and heated to 100degreesC for 5 minutes. Solubilized proteins equivalent to 2x105 cells/20 microl sample were separated by sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE) on 4-12% gradient Bis-Tris NuPage mini-gels with MOPS running buffer (Invitrogen). Following electroblotting to polyvinylidene difluoride membranes (Invitrogen) and blocking with I-Block (Tropix, Applied Biosystems) in phosphate-buffered saline and 0.1% Tween-20 detergent, specific proteins were detected by incubating the membranes with primary antibodies at 4degreesC overnight. The 148.3 and 435.3 mouse anti-TAP1 and TAP2 mAbs were used at 1/100 dilution of culture supernatant, whilst the DA6.147 anti-HLA-DR was used at a 1/250 dilution; the purified mouse mAbs, BZ.1, H68.4, 12CA5, HC10, were used at 1 microg/ml; the rat anti-HA mAb was used at 50 ng/ml; and the goat antibody to calregulin, was used at 1 microg/ml. Primary antibodies specifically bound to blotted proteins were detected by incubation for 30 min with appropriate alkaline phosphatase conjugated secondary antibodies, then were developed using a CDP-Startrade mark detection kit (Tropix, Applied Biosystems) and exposed to autoradiographic film. In one set of experiments, the alkaline-phosphatase-conjugated CleanBlottrade mark immunoprecipitation dection reagent (Thermo Scientific) was used at a 1/500 for 60 min to detect blots of immunoprecipitates being probed with the HC10 mAb.
###end p 84
###begin title 85
T cell function assays
###end title 85
###begin p 86
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Pudney1">[20]</xref>
###xml 457 461 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Long1">[71]</xref>
###xml 474 475 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 573 574 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 803 806 <span type="species:ncbi:10376">EBV</span>
The effector T cell clone, RAK, specific for BZLF1 and restricted through HLA-B8, was generated as described elsewhere [20]. Targets for the RAK clone were generated by transfection of MJS cells (HLA-B8 type) with a BZLF1 expression plasmid with or without a BILF1 expression plasmid. At 24 hr post-transfection, recognition of target cells by the effector T cells was determined by ELISA of IFN- gamma release using a standard protocol described elsewhere [71]. Briefly, 104 effector T cells were incubated for 18 hr at 37degreesC in V-bottom microtest plate wells with 105 target cells, then the supernatants were harvested for quantitation of IFN-gamma by ELISA (Endogen) in accordance with the manufacturer's recommended protocol. Specificity control targets included HLA-matched and HLA-mismatched EBV-transformed lymphoblastoid cell lines (LCL), empty vector-transfected MJS cells, and empty vector-transfected MJS cells pulsed with the RAKFKQLL synthetic peptide.
###end p 86
###begin p 87
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lee2">[72]</xref>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lee2">[72]</xref>
###xml 558 559 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Lee3">[73]</xref>
###xml 639 640 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 896 900 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000255-Long1">[71]</xref>
###xml 43 46 <span type="species:ncbi:10376">EBV</span>
###xml 311 314 <span type="species:ncbi:10376">EBV</span>
LCLs transformed with a BZLF1- recombinant EBV (to prevent induction of endogenous lytic cycle genes) were transduced with control PLZRS-IRES-GFP or PLZRS-BILF1-IRES-GFP retroviruses. These lines were used as targets in assays with a panel of effector T cell clones specific for constitutively expressed latent EBV genes, EBNA1, EBNA3A, LMP2 or BHRF1. The effector T cell clone, HPV, was a CD8+ line specific for EBNA1 and restricted through HLA-B35 [72]; clone YPL was a CD8+ line specific for EBNA3A and restricted through HLA-B35 [72]; clone CLG was a CD8+ line specific for LMP2A and restricted through HLA-A2 [73]; clone PYY was a CD4+ line specific for BHRF1 and restricted through DR4 (Kelly, G.L., Long, H.M. et al, submitted for publication). Recognition of target cells by the effector T cells was determined by ELISA of IFN- gamma release using a standard protocol described elsewhere [71].
###end p 87
###begin title 88
Metabolic Labeling, Immunoprecipitation, and Endo H Digestion
###end title 88
###begin p 89
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 182 184 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 379 380 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 463 464 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 541 542 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1220 1221 1145 1146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 771 <span type="species:ncbi:10090">mouse</span>
Cells (107) were starved with 15 ml methionine-free DMEM medium supplemented with 10% dialysed FCS for 1 h at 37degreesC, then labeled for 15 min with 200 microCi of EasyTag Express 35S protein labeling mix (NEN Life Science Products) in a final volume of 1 ml. After two washes with chase medium (normal DMEM medium supplemented with 10% FCS), the cells were resuspended at 2x106 cells/ml and chased at 37degreesC for the times indicated. Samples containing 2x106 cells were lysed in 400 microl of NP-40 buffer (0.5% Nonidet P-40, 5 mM MgCl2 and 50 mM Tris-HCl, pH 7.5) with protease inhibitor cocktail (Sigma) at 4degreesC for 45 min. Nuclei and insoluble debris were removed by centrifugation, and the supernatants were precleared first with 1.2 microl of normal mouse serum and 20 microl Dynabeads Protein A (Invitrogen) for 2 hr at 4degreesC, and then again with 20 microl Dynabeads Protein A and 20 microl Dynabeads protein G at 4degreesC overnight. The precleared lysates were immunoprecipitated for 2 hr with 6 microl of W6/32 Minipermtrade mark culture supernatant and 20 microl Dynabeads Protein A plus 20 microl Dynabeads protein G, before washing the beads four times with NET buffer (0.5% NP-40, 150 mM NaCl2, 5 mM EDTA and 50 mM Tris-HCl, pH 7.5) and eluting by boiling in reducing gel sample buffer for 5 min. For endoglycosidase H (Endo H) treatment, 20 microl samples were incubated at 37degreesC for 2.5 hr with 2 microl G5 reaction buffer and 1.5 microl of Endo H enzyme (New England Biolabs Inc.). For second-round precipitations, boiled eluates were first diluted 10-fold with lysis buffer, then reprecipitated as above with either HC10 (MHC class I heavy chain) or 3F10 (anti-HA tag on BILF1). Finally, the samples were separated by SDS-PAGE on 10% Bis-Tris NuPage mini-gels with MOPS buffer (Invitrogen). After the gels were fixed and dried, they were exposed to autoradiographic film.
###end p 89
###begin title 90
Cold co-immunoprecipitations
###end title 90
###begin p 91
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 604 605 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For immunoprecipitations from whole cell lysates, 2x106 cells were lysed in 400 microl of NP-40 buffer with protease inhibitors and were immunoprecipitated as above. Lysates were precipitated with 1 microg of either W6/32 (HLA-ABC), 12CA5 (HA-tag; BILF1) or H68.4 (TfR) mAbs. Eluted samples were separated on 4-12% Bis-Tris NuPage mini-gels with MOPS buffer, electroblotted to polyvinylidene difluoride membranes and probed with antibodies HC10 (anti- HLA class I heavy chain), H68.4 (anti-TfR) or 3F10 (anti-HA tag on BILF1). For the selective immunoprecipitation of cell-surface surface molecules, 2x106 cells were incubated for 60 min on ice with saturating amounts of W6/32, H68.4 or 12CA5, then washed three times in PBS. The cells were then lysed in 400 microl of NP-40 buffer with protease inhibitors and immunoprecipitated with 20 microl Dynabeads Protein A plus 20 microl Dynabeads protein G.
###end p 91
###begin title 92
Immunofluorescence staining of fixed cells
###end title 92
###begin p 93
###xml 580 584 <span type="species:ncbi:9925">goat</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
###xml 622 626 <span type="species:ncbi:9925">goat</span>
###xml 632 635 <span type="species:ncbi:10116">rat</span>
293-BILF1 cells were grown on glass slides coated with fibronectin, and were treated with concanamycin A for 6 hrs. For the confocal microscopy, the cells were rinsed with PBS and fixed with 4% (w/v) paraformaldehyde in PBS for 20 min, then permeabilized with 0.5% Triton X-100 in PBS for 5 min. For conventional fluorescence microscopy, the cells were fixed and permeabilized with methanol-acetone (1:1 vol:vol) for 15 min at -20degreesC. The slides were incubated with primary antibodies for 2 hr at 37degreesC, washed extensively in PBS, then incubated with Alexa Fluor(R) 488 goat anti-mouse IgG or Alexa Fluor(R) 594 goat anti-rat IgG secondary antibodies (Invitrogen) for 45 min. After repeated washing the slides were mounted with vectashield mounting medium with DAPI stain (Vector laboratories) and analyzed with a Zies LSM510 laser scanning confocal microscope, or with a Nikon E600 conventional fluorescence microscope.
###end p 93
###begin title 94
Protease inhibitor assays
###end title 94
###begin p 95
###xml 255 256 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
293 cells stably transduced with control or BILF1 retrovirus were treated with Bafilomycin A1 (2 microM), concanamycin A (50 nM), or leupeptin (200 microM) or MG132 (10 microM) for 20 hr. All inhibitors were purchased from Sigma-Aldrich. Lysates from 2x105 cell equivalents were separated by SDS/PAGE gel, and analyzed by Western Blotting using antibodies specific for MHC class I (HC10) and calregulin.
###end p 95
###begin title 96
NFkappaB reporter assays
###end title 96
###begin p 97
###xml 45 46 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 132 139 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 628 635 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 694 701 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
HEK293-NFkappaB-luc cells were seeded at 2x105/ml in a 96-well plate at 24 hr prior to transfection with a constitutively expressed Renilla-luciferase reporter construct (phRL-TK, 70 ng/well, Promega) for normalizing transfection efficiency, together with BILF-wild-type, BILF1-K122A mutant, or empty vector DNA (160 ng/well). The Lipofectamine-2000 (Invitrogen) and DNA mix in Opti-MEM medium was prepared according to the supplier's instructions, and 50 microl was then added to each well. Cell extracts were generated after 48 h using Cell Culture Lysis Buffer (Promega), and extracts were assayed for firefly luciferase and Renilla-luciferase activity using the Luciferase Assay System and Renilla Luciferase Assay System (Promega), respectively.
###end p 97
###begin p 98
We are grateful to Fred Wang (Harvard), Andrew Hislop (Birmingham), David Blackbourn (Birmingham), and Alan Rickinson (Birmingham) for provision of essential reagents and for critical review of the manuscript.
###end p 98
###begin title 99
References
###end title 99
###begin article-title 100
###xml 38 59 <span type="species:ncbi:10359">human cytomegalovirus</span>
Modulation of natural killer cells by human cytomegalovirus.
###end article-title 100
###begin article-title 101
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.
###end article-title 101
###begin article-title 102
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
###end article-title 102
###begin article-title 103
###xml 4 25 <span type="species:ncbi:10359">human cytomegalovirus</span>
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.
###end article-title 103
###begin article-title 104
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
###end article-title 104
###begin article-title 105
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
###end article-title 105
###begin article-title 106
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion.
###end article-title 106
###begin article-title 107
###xml 4 9 <span type="species:ncbi:9606">Human</span>
The Human Cytomegalovirus US10 Gene Product Delays Trafficking of Major Histocompatibility Complex Class I Molecules.
###end article-title 107
###begin article-title 108
###xml 4 25 <span type="species:ncbi:10359">human cytomegalovirus</span>
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
###end article-title 108
###begin article-title 109
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.
###end article-title 109
###begin article-title 110
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
###end article-title 110
###begin article-title 111
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus.
###end article-title 111
###begin article-title 112
###xml 19 37 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Persistence of the Epstein-Barr virus and the origins of associated lymphomas.
###end article-title 112
###begin article-title 113
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus: exploiting the immune system.
###end article-title 113
###begin article-title 114
###xml 41 47 <span type="species:ncbi:9606">humans</span>
###xml 62 80 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.
###end article-title 114
###begin article-title 115
###xml 63 81 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific T cell surveillance.
###end article-title 115
###begin article-title 116
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein Barr Virus Latent Membrane protein-1: Coordinate upregulation of peptide transporters and HLA Class I antigen expression.
###end article-title 116
###begin article-title 117
Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals.
###end article-title 117
###begin article-title 118
###xml 19 37 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface MHC class I and class II.
###end article-title 118
###begin article-title 119
###xml 27 45 <span type="species:ncbi:10376">Epstein-Barr virus</span>
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.
###end article-title 119
###begin article-title 120
###xml 102 105 <span type="species:ncbi:10376">EBV</span>
Impaired Transporter Associated with Antigen Processing-dependent peptide transport during productive EBV Infection.
###end article-title 120
###begin article-title 121
###xml 32 50 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Host shut off during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.
###end article-title 121
###begin article-title 122
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 49 67 <span type="species:ncbi:10376">Epstein-Barr virus</span>
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.
###end article-title 122
###begin article-title 123
The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function.
###end article-title 123
###begin article-title 124
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor.
###end article-title 124
###begin article-title 125
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase.
###end article-title 125
###begin article-title 126
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors.
###end article-title 126
###begin article-title 127
A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.
###end article-title 127
###begin article-title 128
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.
###end article-title 128
###begin article-title 129
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases.
###end article-title 129
###begin article-title 130
Vacuolar ATPase activity is required for endosomal carrier vesicle formation.
###end article-title 130
###begin article-title 131
###xml 136 139 <span type="species:ncbi:10116">rat</span>
Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes.
###end article-title 131
###begin article-title 132
Proteasome inhibitors: valuable new tools for cell biologists.
###end article-title 132
###begin article-title 133
Molecular basis of receptor/G-protein-coupling selectivity.
###end article-title 133
###begin article-title 134
The CD8+ T-Cell Response to an Epstein-Barr Virus-Related Gammaherpesvirus Infecting Rhesus Macaques Provides Evidence for Immune Evasion by the EBNA-1 Homologue.
###end article-title 134
###begin article-title 135
###xml 21 39 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Simian homologues of Epstein-Barr virus.
###end article-title 135
###begin article-title 136
###xml 37 55 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Virus and cell RNAs expressed during Epstein-Barr virus replication.
###end article-title 136
###begin article-title 137
###xml 56 74 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.
###end article-title 137
###begin article-title 138
###xml 34 53 <span type="species:ncbi:37296">human herpesvirus 8</span>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.
###end article-title 138
###begin article-title 139
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
###end article-title 139
###begin article-title 140
###xml 59 78 <span type="species:ncbi:37296">human herpesvirus 8</span>
Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.
###end article-title 140
###begin article-title 141
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.
###end article-title 141
###begin article-title 142
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene.
###end article-title 142
###begin article-title 143
###xml 46 51 <span type="species:ncbi:9606">human</span>
RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor.
###end article-title 143
###begin article-title 144
Activation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells.
###end article-title 144
###begin article-title 145
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
###end article-title 145
###begin article-title 146
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
###end article-title 146
###begin article-title 147
A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition.
###end article-title 147
###begin article-title 148
Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation.
###end article-title 148
###begin article-title 149
The PHD finger: implications for chromatin-mediated transcriptional regulation.
###end article-title 149
###begin article-title 150
RING finger proteins: mediators of ubiquitin ligase activity.
###end article-title 150
###begin article-title 151
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules.
###end article-title 151
###begin article-title 152
###xml 25 60 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor.
###end article-title 152
###begin article-title 153
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes.
###end article-title 153
###begin article-title 154
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4.
###end article-title 154
###begin article-title 155
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
###end article-title 155
###begin article-title 156
Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells.
###end article-title 156
###begin article-title 157
Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.
###end article-title 157
###begin article-title 158
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.
###end article-title 158
###begin article-title 159
###xml 47 65 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.
###end article-title 159
###begin article-title 160
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
###end article-title 160
###begin article-title 161
###xml 36 60 <span type="species:ncbi:45455">rhesus lymphocryptovirus</span>
###xml 88 106 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.
###end article-title 161
###begin article-title 162
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
###end article-title 162
###begin article-title 163
###xml 20 25 <span type="species:ncbi:9606">human</span>
Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin.
###end article-title 163
###begin article-title 164
Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
###end article-title 164
###begin article-title 165
###xml 45 63 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral "hairy" leukoplakia.
###end article-title 165
###begin article-title 166
###xml 77 82 <span type="species:ncbi:9606">human</span>
Production of a monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.
###end article-title 166
###begin article-title 167
Monoclonal-antibodies raised against denatured HLA-B locus heavy-chains permit biochemical-characterization of certain HLA-C locus products.
###end article-title 167
###begin article-title 168
###xml 42 47 <span type="species:ncbi:9606">human</span>
Two populations of Ia-like molecules on a human B cell line.
###end article-title 168
###begin article-title 169
Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells.
###end article-title 169
###begin article-title 170
###xml 25 43 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 45 48 <span type="species:ncbi:10376">EBV</span>
###xml 95 98 <span type="species:ncbi:10376">EBV</span>
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.
###end article-title 170
###begin article-title 171
###xml 49 67 <span type="species:ncbi:10376">Epstein-Barr virus</span>
CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1.
###end article-title 171
###begin article-title 172
###xml 61 79 <span type="species:ncbi:10376">Epstein-Barr virus</span>
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
###end article-title 172
###begin p 173
The authors have declared that no competing interests exist.
###end p 173
###begin p 174
This work was supported by a grant from the Wellcome Trust, London (085852/Z/08/Z) and by the University of Birmingham, UK. Additional support for BG, MER, and EJHJW was from the Dutch Cancer Society (UL 2005-3259), the M.W. Beijerinck Virology Fund of the Royal Academy of Arts and Sciences, and the Netherlands Organisation for Scientific Research (Vidi 917.76.330).
###end p 174

